Clinical Trial Update: BIOMARKERS FOR DRUG SELECTION IN DEPRESSION

View source ↗

Summary

A clinical trial investigating biomarkers to guide drug selection for major depressive disorder has completed, sponsored by Neomente SAS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Neomente SAS | Conditions: Depression - Major Depressive Disorder | Status: COMPLETED